NCT06660693View on ClinicalTrials.gov

Comparison of Medical RESCUE Strategies for Patients With Steroid-refractory Acute Severe Ulcerative Colitis

PHASE3RecruitingINTERVENTIONAL

Enrollment

134

Participants

Timeline

Start Date

April 16, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

September 30, 2027

Conditions

Colitis, Ulcerative

Interventions

DRUG

Upadacitinib Oral Product

Upadacitinib oral 45mg once daily.

Trial Locations (1)

L8L 2X2

RECRUITING

Hamilton Health Sciences, Hamilton

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AbbVie

INDUSTRY

lead

McMaster University

OTHER